Rinucumab (Anti-PDGFRB / CD140b)

Ask supplier a question | View on supplier's website

Rinucumab (Anti-PDGFRB / CD140b) is an anti-platelet-derived growth factor receptor beta (anti-PDGFR-beta) monoclonal antibody and has a potential to study neovascular age-related macular degeneration. MW: 145.5 kD.

Supplier	Selleck Chemicals
Product #	A2378
Sku #	A2378-1mg*25
Pricing	1mg*25, $5070.00

Feedback